As of June 23, 2025, Mckesson Corp (MCK) reports a Net Margin of 0.92%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of Mckesson Corp's Net Margin
Over recent years, Mckesson Corp's Net Margin has shown significant volatility. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2025-03-31 | 0.92% |
| 2024-03-31 | 0.97% |
| 2023-03-31 | 1.29% |
| 2022-03-31 | 0.42% |
| 2021-03-31 | -1.91% |
This slight downward trend highlights how Mckesson Corp manages its overall profitability and cost control over time.
Comparing Mckesson Corp's Net Margin to Peers
To better understand Mckesson Corp's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| Mckesson Corp (MCK) | 0.92% |
| Fuse Medical Inc (FZMD) | 16.63% |
| Premier Inc (PINC) | 8.88% |
| China BCT Pharmacy Group Inc (CNBI) | 8.70% |
| Global Pharm Holdings Group Inc (GPHG) | 7.95% |
| Haemato AG (HAEK.DE) | 3.30% |
Compared to its competitors, Mckesson Corp's Net Margin is about average compared to peers, reflecting typical industry profitability.